Large-scale production of bioactive recombinant human acidic fibroblast growth factor in transgenic silkworm cocoons

• DOI: 10.1038/srep16323
• Publication Date: 2015-11-16T10:07:14Z
• Authors: Feng Wang; Riyuan Wang; Yuancheng Wang; Ping Zhao; Qingyou Xia
• Keywords: 0301 basic medicine; Gene Expression; Bombyx; Article; Protein Refolding; Recombinant Proteins; Animals, Genetically Modified; Mice; 03 medical and health sciences; Bioreactors; Cell Movement; DNA Transposable Elements; NIH 3T3 Cells; Animals; Fibroblast Growth Factor 1; Humans; Cell Proliferation

AbstractWith an increasing clinical demand for functional therapeutic proteins every year, there is an increasing requirement for the massive production of bioactive recombinant human acidic fibroblast growth factor (r-haFGF). In this present study, we delicately explore a strategy for the mass production of r-haFGF protein with biological activity in the transgenic silkworm cocoons. The sequence-optimized haFGF was inserted into an enhanced sericin-1 expression system to generate the original transgenic silkworm strain, which was then further crossed with a PIG jumpstarter strain to achieve the remobilization of the expression cassette to a “safe harbor” locus in the genome for the efficient expression of r-haFGF. In consequence, the expression of r-haFGF protein in the mutant line achieved a 5.6-fold increase compared to the original strain. The high content of r-haFGF facilitated its purification and large-scald yields. Furthermore, the r-haFGF protein bioactively promoted the growth, proliferation and migration of NIH/3T3 cells, suggesting the r-haFGF protein possessed native mitogenic activity and the potential for wound healing. These results show that the silk gland of silkworm could be an efficient bioreactor strategy for recombinant production of bioactive haFGF in silkworm cocoons.